Back to Search Start Over

[Central serous chorioretinopathy: A review].

Authors :
Bousquet E
Provost J
Torres-Villaros H
Behar-Cohen F
Source :
Journal francais d'ophtalmologie [J Fr Ophtalmol] 2023 Sep; Vol. 46 (7), pp. 791-802. Date of Electronic Publication: 2023 Jun 03.
Publication Year :
2023

Abstract

The central serous chorioretinopathy (CSCR) is characterized by serous retinal detachments SRD associated with one or several retinal pigment epithelium detachments/irregularities (PEDs). The choroid is thickened with dilated choroidal veins and choroidal hyperpermeability suggesting an underlying choroidopathy. CSCR belongs to the pachychoroid spectrum. CSCR affects mostly middle-aged men and the main risk factor is the corticosteroid intake. In most cases, the subretinal detachment resolves spontaneously with a good visual prognosis. However, recurrent or chronic form of the disease can lead to irreversible retinal damage and decreased visual acuity. Laser on an extra foveal leak point or half dose/half fluence photodynamic therapy are the first-line treatment options.<br /> (Copyright © 2023. Published by Elsevier Masson SAS.)

Details

Language :
French
ISSN :
1773-0597
Volume :
46
Issue :
7
Database :
MEDLINE
Journal :
Journal francais d'ophtalmologie
Publication Type :
Academic Journal
Accession number :
37277234
Full Text :
https://doi.org/10.1016/j.jfo.2023.02.003